Ipilimumab or FOLFOX in Combination With Nivolumab and Trastuzumab in HER2 Positive EsophagoGastric Adenocarcinoma

Conditions:   Gastric Cancer;   Esophageal Cancer;   Adenocarcinoma Gastric;   HER2 Positive Gastric Cancer;   Metastatic Gastric Cancer;   GastroEsophageal Cancer
Interventions:   Drug: Nivolumab;   Drug: Ipilimumab
Sponsors:   AIO-Studien-gGmbH;   Bristol-Myers Squibb
Not yet recruiting

http://ift.tt/2G8Idku